Nod2 nucleic acids and proteins
CA 2427684 C · Owner: The Regents Of The University Of Michigan · Inventors: Nunez, Gabriel; Inohara, Naohiro; Ogura, Yasunori
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to intracellular signaling molecules in , particular the Nod2 protein and nucleic acids encoding the Nod2 protein. The present invention provides isolated nucleotide sequence encoding Nod2 isolated Nod2 peptides, antibodies that specifically bind Nod2 methods for , the detection of Nod2, and methods for screening compounds for the ability to alter Nod2 associated signal transduction.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 2001 and granted March 6, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.